| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.12 | 0.4 |